Illumina Wins Case Against FTC on Grail Acquisition
10 Articles
10 Articles
U.S. judge backs Illumina deal for Grail in blow to FTC
WASHINGTON -- A U.S. administrative judge has ruled in favor of Illumina Inc's acquisition of cancer detection test maker Grail Inc, the U.S. maker of genetic analysis equipment said on Thursday. Read More
Administrative Law Judge Rules in Favor of Illumina in FTC Challenge to Grail Deal
Pioneering San Diego genomics leader Illumina announced Thursday that an administrative law judge had cleared its acquisition of spinoff cancer detection test maker Grail.
Illumina Wins Case Against FTC on Grail Acquisition
Illumina Inc. won a US Federal Trade Commission lawsuit seeking to unwind its $7 billion acquisition of cancer-startup Grail Inc. after an administrative judge ruled the tie-up didn’t violate antitrust law, the company said.
Coverage Details
Bias Distribution
- 70% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium








